ONCOLOGICAL RESULTS OF SURGICAL TREATMENT EFFECTIVENESS OF STAGE I AND II ORAL CAVITY CANCER

Introduction. Surgical intervention is the main method of treatment of oral cavity cancer, and at early stages it»s a monomodal treatment. The study objective is to determine oncological effectiveness based on an analysis of surgical treatment of stage I and II oral cancer.

Materials and methods. In the period from April 2009 to December 2014, 52 patients (37 men and 15 women) aged 39–85 (mean age was 60.2 years) with confirmed diagnosis of squamous cell carcinoma of the tongue (36 patients), the floor of the mouth (15), and the retromolar trigone (1) underwent surgery. Half of the patients were stage I, the other half – stage II. Removal of the primary tumor was accompanied by neck dissection in 35 cases (67 %). Dissection was two-sided in 8 patients. Twenty (20) modified radical dissections and 23 selective neck dissections were performed. In the majority of cases (42 patients, 80.8 %), tumors were removed transorally. Primary reconstruction was performed in 31 patients; in others, additional plastic material was used: infrahyoid flap (14 cases), submental flap (1), radial forearm flap (5), anterolateral femoral flap (1). Survival was evaluated using the Kaplan–Meier estimator incorporating patient’ dates of last visits or death. Progression-free survival took into account time to diagnosis of disease relapse in the form of local or regional recurrence. Statistical data analysis was performed using the SPSS v. 23 software.

Results. Mean follow up duration was 37.4 months (1–91  months), and 27 patients (52 %) were monitored for 3 and more years, 34 (65.4 %) patients after surgery for 2 years and longer, and 46 (88.5 %) patients for more than a year. During this time, 8 patients died, and 3-year overall survival was 84.7 %. In 6 patients, disease recurrence was diagnosed, in 2 of them this event was registered twice (local recurrence in 3 cases, regional recurrence in 4 cases, locoregional recurrence in 1 case). Therefore, locoregional control was 88.5 %. Time to recurrence varied from 4 to 43 months. Three-year relapse-free survival was 91.1 %. Second primary tumors appeared 30–70  months after surgery in 4 patients: In 2 patients, they were located in the oral cavity, in 1 – in the larynx, and in 1 – in the laryngopharynx. Statistical analysis of various factors (Т stage, differentiation grade, localization, etc.) has shown that only neck dissection affected overall 3-year survival: it was 96 % in patients with neck dissection, and 64.3 % in patients without neck dissection (р = 0.012). However, these data can be explained by older age of patients who didn’t undergo neck lymph node dissection (65.2 vs. 57.6 years), and presence of a more severe concomitant pathology.

Conclusion. Surgical intervention remains the main treatment method of early stage oral cavity cancer due to its high oncological effectiveness.

1. Клинические рекомендации по лечению опухолей головы и шеи: Справочник специалиста по лечению опухолей головы и шеи. М.: АБВ-пресс, 2011. [Clinical guidelines for treatment of neck and head tumors: Reference book for specialists in head and neck tumors. Moscow: ABV-Press, 2001. (In Russ.)].

2. Pimenta Amaral T.M., da Silva Freire A.R., Carvalho A.L. et al. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 2004;4(8):780–6. DOI: 10.1016/j.oraloncology. 2003.10.009. PMID: 15288831.

3. Garziano-Demo P., Dell, Acqua A., Dalmasso P. et al. Clinicopathologic parameters and outcome of 245 patients operated of oral squamous cell carcinoma. J Craniomaxillofac Surg 2006;34(6):344–50. DOI: 10.1016/j.jcms.2006.04.004. PMID: 16859913.

4. Peng K., Chu A., Lai C. et al. Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience. Am J Otolaryngol 2014;35(6):741–6. DOI: 10.1016/j.amjoto.2014.06.019. PMID: 25091179.

5. Pezier T., Nixon I., Gurney B. et al. Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma – a prospective case series. Ann Surg Oncol 2012;19 (11):3528–33. DOI: 10.1245/s10434-011-2207-0. PMID: 22411202.

6. Канаев С.В. Лучевая терапия злокачественных опухолей головы и шеи. Практическая онкология 2003;4(1):15–24. [Kanaev S.V. Beam therapy of malignant tumors of the head and neck. Prakticheskaya onkologiya = Practical oncology 2003;4(1):15–24. (In Russ.)].

7. Геворков. А.Р. Индивидуализация показаний к проведению лучевого, химиолучевого лечения больных плоскоклеточным раком языка. Автореф. дис. … канд. мед. наук. М., 2013. [Gevorkov A.R. Individualization of indications for beam therapy, chemoradiation treatment in patients with squamous cell carcinoma of the tongue. Ph. D. dissertation summary. Moscow, 2013. (In Russ.)].

8. Семин Д.Ю. Одновременная химиолучевая терапия рака слизистой оболочки полости рта и ротоглотки. Вопросы онкологии 2010;56(5):544–7. [Siomin D.Yu. Concurrent radiochemotherapy in the treatment of squamous cell oral and oropharyngeal cancer. Voprosy onkologii = Problems in Oncology 2010;56(5):544–7. (In Russ.)].

9. Henk K. Treatment of oral cancer by interstitial irradiation using iridium-192. Br J Oral Maxillofac Surg 1992;30(6):355–9. DOI: 10.1016/0266–4356 (92) 90200–3. PMID: 1450156.

10. Dik E., Willems S., Ipenburg N. et al. Resection of early oral squamous cell carcinoma with positive or close margins: relevance of adjuvant treatment in relation to local recurrence: margins of 3 mm as safe as 5 mm. Oral Oncology 2014;50(6):611–5. DOI: 10.1016/j.oraloncology. 2014.02.014 PMID: 24630900.

11. Dwivedi R.C., St Rose S., Chisholm E.J.et al. Evaluation of factors affecting posttreatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur Arch Otorhinolaryngol 2012;269(2):591–9. DOI: 10.1007/s00405-011-1621-z. PMID: 21553147.

12. Zhang T., Lubek J., Salama A. et al. Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg 2014;72(2):406–14. DOI: 10.1016/j.joms.2013.05.028. PMID: 24045188.

13. Fukano H., Matsuura H., Hasegawa Y. et al. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 1997;19(3):205–10. PMID: 9142520.

14. Balasubramanian D., Ebrahimi A., Gupta R. et al. Tumour thickness as a predictor of nodal metastases in oral cancer: comparison between tongue and floor of mouth subsites. Oral Oncology 2014;50(12):1165–8. DOI: 10.1016/j.oraloncology.2014.09.012. PMID: 25307875.

15. Rigual N., Douglas W., Lamonica D. et al. Sentinel lymph node biopsy: a rational approach for staging T2N0 oral cancer. Laryngoscope 2006; 115(12):2217–20. DOI: 10.1097/01.mlg.0000187870.82699.ed. PMID: 16369170.

16. Deganello A., Manciocco V., Dolivet G. et al. Infrahyoid fascio-myocutaneous flap as an alternative to free radial forearm flap in head and neck reconstruction. Head Neck 2007;29(3):285–91. DOI: 10.1002/hed.20512. PMID: 17230563.

17. You Y., Chen W., Wang Y. et al. The feasibility of facial-submental artery island myocutaneous flaps for reconstructing defects of the oral floor following cancer ablation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):e12–e6. DOI:10.1016/j.tripleo.2010.02.004. PMID: 20451829.

18. Leon X., Quer M., Diez S. et al. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21(3):204–10. PMID: 10208662.

19. Yamamoto E., Shibuya H., Yoshimura R. et al. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 2002;94(7):2007–14. DOI: 10.1002/cncr.10444. PMID: 11932903.

20. Strojan P., Corry J., Eisbruch A. et al. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck 2015;37(1):134–50. DOI: 10.1002/hed.23542. PMID: 24481720.